Chinas 2013 Life Sciences Industry Outlook and Regulatory Review
Chinas 2013 Life Sciences Industry Outlook and Regulatory Review
Government Investments Could Make China the Third-largest Pharmaceutical Market in the World
31-Oct-2013
Global
$4,950.00
Special Price $3,712.50 save 25 %
Description
China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the government’s considerable investment in the healthcare industry and the population’s unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and market opportunities in China’s life sciences industry—the regulatory environment, the registration pathway of various drugs and IVD products, and M&A. Medical devices and the related registration pathway are not included. In this study, the base year is 2012, and the forecast period runs 2013–2017. An analysis of market challenges, drivers, and restraints impacting industry growth are provided.
Table of Contents
Analysis of China's Life Sciences Market Outlook and Regulatory Review, 2013
- Overview
No Index | Yes |
---|---|
Podcast | No |
Author | Blair Dong |
WIP Number | P799-01-00-00-00 |
Is Prebook | No |